Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
Author:
Funder
King Saud University
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacology
Reference62 articles.
1. Chondroitin Sulfate-chitosan Nanoparticles for Ocular Delivery of Bromfenac Sodium: Improved Permeation, Retention, and Penetration;Abdullah,2016
2. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics;Ahmed;Drug Des. Devel. Ther.,2015
3. In vitro assessment of the anticancer activity of simvastatin-loaded microemulsion in liver and colon cancer cells;Alkhatib;J. Drug Deliv. Sci. Technol.,2014
4. Review of polysaccharide particle-based functional drug delivery;Barclay;Carbohydr. Polym.,2019
5. Repurposing of statins via inhalation to treat lung inflammatory conditions;Bradbury;Adv. Drug Deliv. Rev.,2018
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy;Biomaterials Advances;2024-01
2. Chitosan Nanoparticles Modified by Anredera cordifolia (Ten.) Steenis Leaf Extract for Enhancement of Azithromycin Encapsulation Efficiency and Loading Capacity: In vitro Drug Release Study;Journal of Pharmaceutical Sciences;2023-12
3. Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin;International Journal of Biological Macromolecules;2023-12
4. Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma;Journal of Clinical Medicine;2023-10-31
5. Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety Assessment;AAPS PharmSciTech;2023-09-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3